Cellebrite DI Sees Q3 Sales $145.000M-$148.000M vs $150.298M Est
Benzinga Newsdesk 2 months ago
NewsGuidance
Cellebrite DI (NASDAQ:CLBT) sees Q3 sales of $145.000 million-$148.000 million vs $150.298 million analyst estimate.
Cellebrite DI (NASDAQ:CLBT) sees Q3 sales of $145.000 million-$148.000 million vs $150.298 million analyst estimate.